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intrOdUctiOn
Reading EKGs is an integral skill in Emergency 
Medicine, especially given the fact that determining the 
presence and amount of ST segment elevation (STE) is one 
of the key factors to initiating fibrinolytic eligibility. STE is 
generally measured in reference to the J point (the end of the 
QRS segment and the beginning of the ST segment). However, 
it may not be clear in clinical practice where the J point starts, 
where one measures ST segment elevation in relation to the 
J point and finally what the exact degree of elevation of the 
ST segment makes one a candidate for thrombolysis. Further 
complicating the issue are numerous other causes of J point 
and ST segment elevation that are not myocardial-infarction 
related. This short review will focus on identifying the J point 
in order to determine an accurate measurement of ST segment 
elevation and its relationship to fibrinolytic eligibility.
the J point: where is it?
One standard text defines J point elevation as: “the point 
where the QRS ends and the ST segment begins.”1 Where 
exactly that “point” resides is rarely stated. One of the more 
specific descriptors states that the J point is the “first point of 
the inflection on the upstroke of the S wave.”2 This 
Figure 1. Examples of J point determination
description gives one at least some hope of finding a specific 
point from which to measure. However, we know of no study 
that has specifically determined the interrater reliability of 
J point measurements. Studies of the interrater reliability of 
degree of STE have been performed and generally show con-
siderable disagreement.2,3 Since this “point” may be subtle and 
depend on a variety of factors (the investigator’s vision for 
example), it may be surmised that the interrater reliability of J 
point measurement may be less than perfect (Figure 1).
ste and the J point
In theory the ST segment is normally neither elevated nor 
depressed. STE should be measured from the upper edge of 
the P-R segment (not the T-P segment) to the upper edge of the 
ST segment at the J point.4 In most patients, however, the T-P 
segment and P-R segment lie on the same plane.5 Likewise, 
ST segment depression should be measured from the lower 
edge of the P-R segment to the lower edge of the ST segment 
at the J point. If the ST segment is measured with reference 
to the T-P segment, atrial repolarization with a prominent 
negative T wave may result in an inaccurate measurement.4 
(See Figure 2).
It is unclear whether STE measured at the J point or 60 
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milliseconds after the J point is superior when evaluating 
fibrinolytic or PTCA criteria.6,7,8,9,10 A recent retrospective 
study showed that fewer EKGs met enrollment criteria when 
based on STE at the J point versus at 60 ms after the J point. 
Fewer EKGs met an ST score (sum of STE in leads V1-V6) of 
6 mm when measured at the J point versus J point plus 60
milliseconds (70% vs. 88%).6 This controversy is not likely to 
be resolved any time soon and, in most cases, is probably not 
important. It is a reminder, however, that criteria that appear 
to be set in stone, well defined, and closely followed by all 
experts, are in fact open to interpretation and bias.
what degree of ste equals Fibrinolytic criteria?
Marriot’s criteria states that cardiac injury is present 
when the J point is either elevated by 1 mm or greater in 
two or more limb leads (or pre-cordial leads V4 to V6), by 2 
mm or greater in two or more pre-cordial leads V1 to V3, or 
is depressed by 1 mm or greater in two or more pre-cordial 
leads V1 to V3.5 Recently, there has been a move away from 
requiring a 2 mm elevation in the anterior pre-cordial leads. 
The American College of Emergency Physicians (ACEP) 
Clinical Policies Committee’s 2000 revision states that 
fibrinolytic criteria includes “ST-segment elevations greater 
than 0.1 mV in two or more contiguous leads that are not 
characteristic of early repolarization or pericarditis, nor of 
a repolarization abnormality from LVH or BBB in patients 
with clinical presentation suggestive of AMI.”10 This was 
a level “B” recommendation, and the review notes that the 
fibrinolytic trials have used different criteria. This move to a 1 
mm elevation in any lead is supported by Pope and colleagues 
who found that a full 30% of patients who have ST-segment 
elevation of 1 mm or greater had a final diagnosis of AMI 
in their multicenter study. Alarmingly, the authors also note 
a small but important incidence (11%) of failure by the ED 
clinician to detect ST-segment elevations of 1 to 2 mm in the 
EKGs of patients who had AMI.11 
Table 1. ECG Entrance Criteria in Select Mega-Trials
Study Publica-
tion Year
Duration of 
Symptoms 
Required
Maximum Time 
to Onset Prior to 
Presentation
EKG Change Requirements Other Require-
ments/Modifiers
ISIS - 1 (13) 1986 ----- 12 hr None MI suspected by MD
ISIS - 1 (14) 1988 ----- 24 hr None MI suspected by MD
GISSI - 2 (15) 1990 ----- 6 hr 1) STE > 1mm in any limb lead
2) STE > 2mm in any precordial lead
ISIS - 3 (16) 1992 ----- ----- None MD thought there 
was a “clear” indica-
tion for Fibrinolytics
GUSTO (17) 1993 20 min 6 hr 1) STE > 0.1mV in 2 or more limb leads
2) STE > 0.2mV in 2 or more contiguous precordial leads
GUSTO III (18) 1997 30 min 6 hr 1) STE > 1mm in 2 or more limb leads
2) STE > 2mm in precordial leads
3) BBB
ASSENT - 2 (19) 1999 ----- 6 hr 1) STE > 0.1mV in 2 or more limb leads
2) STE > 0.2mV in 2 or more contiguous precordial leads
3) LBBB
InTIME - II (20) 2000 30 min 6 hr 1) STE > 0.1mV in any 2 contiguous limb leads
2) STE > 0.2mV in any 2 contiguous precordial leads
3) STE > 0.2mV in V4R
4) STE > 0.2mV in 2 contiguous posterior leads
5) New or presumed new LBBB
ASSENT - 3 (21) 2001 ----- 6hr 1) STE > 0.1mV in 2 or more limb leads
2) STE > 0.2mV in 2 or more contiguous precordial leads
3) LBBB
GUSTO V (22) 2001 30 min 6hr “EKG criteria for STEMI or New LBBB” (with references 
to GUSTO, GUSTO III & ASSENT – 2)
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It is interesting that many of the largest mega-trials used 
quite different criteria for fibrinolytic eligibility (Table 1). 
Indeed some of the mega-trials used no explicit ST segment 
criteria. The current criteria are derived from retrospective 
analysis of a combination of mega-trials and therefore 
have been open to interpretation. The use of 1mm in any 2 
contiguous leads has also been deemed acceptable by the 
American College of Cardiology/American Heart Association 
(ACC/AHA) guidelines.12 Regardless, it is best to interpret the 
ST segment in relation to the clinical history. The higher the 
pre-test probability of AMI the more comfort one should have 
in accepting 1mm versus 2mm of ST segment elevation as the 
criteria for thrombolysis.
sUMMarY
The exact location of the J point, as well as its use for 
determining STE is open to some debate. Even the exact place 
to measure ST segment elevation for fibrinolytics is a point 
of contention, as is the degree of ST segment elevation that 
warrants consideration of fibrinolytic therapy. Interpreting ST 
segment elevation must be made in the context of the clinical 
setting. Like any test, the pre-test probability of the disease 
(myocardial infarction in this case) is essential in interpreting 
the results of the test (degree, type and amount of ST segment 
elevation).
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